TITLE

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

AUTHOR(S)
Leclercq, I. A.; Sempoux, C.; Stärkel, P.; Horsmans, Y.
PUB. DATE
July 2006
SOURCE
Gut;Jul2006, Vol. 55 Issue 7, p1020
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aim: Peroxisome proliferator activated receptor γ (PPARγ) agonists have been shown to prevent hepatic fibrosis in rodents. We evaluated the therapeutic antifibrotic potential of the PPARγ agonist pioglitazone on established hepatic fibrosis. Methods: Repeated injections of carbon tetrachloride (CCl4), a choline deficient diet, or bile duct ligation (BDL) were used to induce hepatic fibrosis in rats. Pioglitazone treatment was introduced at various time points. Therapeutic efficacy was assessed by comparison of the severity of hepatic fibrosis in pioglitazone treated versus untreated fibrotic controls. Results: When introduced after two weeks of CCl4, pioglitazone reduced hepatic fibrosis, OH proline content, hepatic mRNA expression of collagen type I, and profibrotic genes, as well as the number of activated α smooth muscle actin positive hepatic stellate cells, compared with rats receiving CCl4 only, with no significant change in necroinflammation. When pioglitazone treatment was initiated after five weeks of CCl4, no antifibrotic effect was observed. Similarly, pioglitazone was associated with a reduced severity of fibrosis induced by a choline deficient diet when introduced early, while delayed treatment with pioglitazone remained ineffective. In contrast, pioglitazone failed to interrupt progression of fibrosis due to BDL, irrespective of the timing of its administration. Conclusion: In rats, the therapeutic antifibrotic efficacy of pioglitazone is limited and dependent on the type of injury, duration of disease, and/or the severity of fibrosis at the time of initiation of treatment.
ACCESSION #
21399633

 

Related Articles

  • The Protective Effect of Glycyrrhetinic Acid on Carbon Tetrachloride-Induced Chronic Liver Fibrosis in Mice via Upregulation of Nrf2. Shaoru Chen; Liyi Zou Li Li; Tie Wu; Uversky, Vladimir N. // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    This study was designed to investigate the potentially protective effects of glycyrrhetinic acid (GA) and the role of transcription factor nuclear factor-erythroid 2(NF-E2)-related factor 2 (Nrf2) signaling in the regulation of Carbon Tetrachloride (CCl4)-induced chronic liver fibrosis in mice....

  • Dehydroepiandrosterone and Its Derivatives: Potentially Novel Anti-Proliferative and Chemopreventive Agents. Matsuzaki, Y.; Honda, A. // Current Pharmaceutical Design;Sep2006, Vol. 12 Issue 26, p3411 

    Dehydroepiandrosterone (DHEA) is the most abundant adrenal androgenic steroid in young adult humans. The physiological functions of DHEA in preventing human carcinogenesis are still controversial, but a lot of reports have shown that pharmacological doses of DHEA show chemopreventive and...

  • Corrections.  // Gut;Aug2015, Vol. 64 Issue 8, p137 

    A correction to the article "Pathobiology of Liver Fibrosis †A Translational Success Story" by Y. A. Lee that was published in a 2015 issue of the periodical is presented.

  • Corrections.  // Gut;Aug2015, Vol. 64 Issue 8, p1337 

    A correction to the article "Pathobiology of Liver Fibrosis - A Translational Success Story" by Y. A. Lee that was published in a 2015 issue of the periodical is presented.

  • F2-isoprostanes stimulate collagen synthesis in activated hepatic stellate cells: a link with liver fibrosis? Comporti, Mario; Arezzini, Beatrice; Signorini, Cinzia; Sgherri, Cristiana; Monaco, Barbara; Gardi, Concetta // Laboratory Investigation (00236837);Nov2005, Vol. 85 Issue 11, p1381 

    Carbon tetrachloride (CCl4)-induced hepatic fibrosis has been considered to be linked to oxidative stress and mediated by aldehydic lipid peroxidation products. In the present study, we investigated whether collagen synthesis is induced by F2-isoprostanes, the most proximal products of lipid...

  • Hepatoprotective effect of Matrine salvianolic acid B salt on Carbon Tetrachloride-Induced Hepatic Fibrosis.  // Journal of Inflammation;2012, Vol. 9 Issue 1, p16 

    The article presents a study which examines the hepoprotective effect of Matrine salvianolic acid B salt on carbon tetrachloride (CCI4)-induced hepatic fibrosis. The study utilizes Wistar rats to analyze hepatic fibrosis induced by CCI4. It reveals that matrine salvianolic acid B salt treatment...

  • Smad3 Deficiency Ameliorates Hepatic Fibrogenesis through the Expression of Senescence Marker Protein-30, an Antioxidant-Related Protein. Da-Hee Jeong; Meeyul Hwang; Jin-Kyu Park; Moon-Jung Goo; Il-Hwa Hong; Mi-Ran Ki; Akihito Ishigami; Ah-Young Kim; Eun-Mi Lee; Eun-Joo Lee; Kyu-Shik Jeong // International Journal of Molecular Sciences;Dec2013, Vol. 14 Issue 12, p23700 

    Smad3 is a key mediator of the transforming growth factor (TGF)-ß1 signaling pathway that plays central role in inflammation and fibrosis. In present study, we evaluated the effect of Smad3 deficiency in Smad3-/- mice with carbon tetrachloride (CCl4)-induced liver fibrosis. The animals were...

  • Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis. Dixon, Laura J; Berk, Michael; Thapaliya, Samjhana; Papouchado, Bettina G; Feldstein, Ariel E // Laboratory Investigation (00236837);May2012, Vol. 92 Issue 5, p713 

    Non-alcoholic steatohepatitis (NASH) is typically associated with pro-apoptotic caspase activation. A potential role for pro-inflammatory caspases remains incompletely understood. Our aims were to examine a potential role of caspase-1 in the development of liver damage and fibrosis in NASH....

  • Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases. Handa, Priya; Kowdley, Kris V. // Annals of Hepatology: Official Journal of the Mexican Associatio;Jan/Feb2014, Vol. 13 Issue 1, p152 

    The article offers information on hepatic inflammation and fibrosis in chronic liver diseases. Chronic liver injury is said to be characterized by inflammation and fibrosis. Hepatocellular carcinoma and end-stage liver disease can be caused by unresolved progression of fibrosis. Chronic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics